Stay updated with breaking news from Robert Doyle. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Indianapolis, April 2: Imagine getting the benefits of gastric bypass surgery without having to go under the knife -- a new class of compounds may be able to do just that. These potential treatments significantly reduce body weight and blood glucose levels in laboratory animals.
Gastric bypass and related procedures, known collectively as bariatric surgery, offer one solution, often resulting in lasting weight loss and even remission of diabetes. But these operations carry risk, aren't suitable for everyone and aren't accessible for many of the hundreds of millions of people worldwide who are obese or diabetic. As an alternative, Doyle says, they could tackle their metabolic problems with a drug that replicates the long-term benefits of surgery.
A potential new drug could curb appetite without causing nausea and vomiting side effects, research with lab animals suggests.
A new treatment could give Ozempic and Wegovy a run for their money.
Indianapolis, March 29: Imagine getting the benefits of gastric bypass surgery without having to go under the knife -- a new class of compounds may be able to do just that. These potential treatments significantly reduce body weight and blood glucose levels in laboratory animals.